Metastatic Head and Neck Carcinoma
Also known as: Head and neck cancer stage IV / Stage IV Head and Neck Cancer
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00112 | Bevacizumab | 1 | Completed | 1 |
| DB00112 | Bevacizumab | 1 | Recruiting | 1 |
| DB08875 | Cabozantinib | 1 | Active Not Recruiting | 1 |
| DB00515 | Cisplatin | 1 | Completed | 1 |
| DB00531 | Cyclophosphamide | 1 | Recruiting | 1 |
| DB01248 | Docetaxel | 1 | Completed | 1 |
| DB00530 | Erlotinib | 1 | Completed | 1 |
| DB17474 | Exlinkibart | 1 | Recruiting | 1 |
| DB00544 | Fluorouracil | 1 | Recruiting | 1 |
| DB01005 | Hydroxyurea | 1 | Recruiting | 1 |
| DB09035 | Nivolumab | 1 | Active Not Recruiting | 1 |
| DB01229 | Paclitaxel | 1 | Recruiting | 1 |
| DB14769 | Pamiparib | 1 | Recruiting | 1 |
| DB14922 | Tislelizumab | 1 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 / 2 | Recruiting | 1 |
| DB08875 | Cabozantinib | 2 | Active Not Recruiting | 1 |
| DB00002 | Cetuximab | 2 | Active Not Recruiting | 1 |
| DB16296 | IPI-549 | 2 | Recruiting | 1 |
| DB14933 | Nicotinamide riboside | 2 | Terminated | 1 |
| DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
| DB01229 | Paclitaxel | 2 | Active Not Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Active Not Recruiting | 2 |
| DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
| DB14797 | SEphB4-HSA | 2 | Active Not Recruiting | 1 |
| DB00820 | Tadalafil | 2 | Recruiting | 1 |